Matsuyama T, Shiosaka S, Wanaka A, Yoneda S, Kimura K, Hayakawa T, Emson P C, Tohyama M
J Comp Neurol. 1985 May 8;235(2):268-76. doi: 10.1002/cne.902350209.
This study shows (1) the ultrastructure of vasoactive intestinal polypeptide (VIP)-, substance P (SP)-, and neuropeptide Y (NPY)-containing nerve fibers in the walls of the cerebral arteries and (2) the relationship between these peptidergic (VIP, SP, and NPY) and catecholaminergic (CA) nerve terminals by immunohistochemistry combined with false transmitter (5-hydroxydopamine) histochemistry under the electron microscope. VIP-, SP-, and NPY-like immunoreactivity (VIPI, SPI, and NPYI) were found diffusely in the axoplasm and around the small clear vesicles in the nerve terminals. In a few cases, SPI was found within the large vesicles. Most of the VIPI terminals were ensheathed by the cytoplasm of the Schwann cells together with CA terminals, identified as those with a number of small granulated vesicles. In some cases, they were directly apposed to the smooth muscle cells at a distance of about 100 nm. SPI terminals were frequently solitary but about 30% were located together with CA and other (neither SPI nor CA) terminals ensheathed by Schwann cells, directly apposed to the smooth muscle cells at a distance of about 100 nm. On the other hand, NPYI terminals were also identified as CA terminals, indicating the coexistence of these two substances. These findings suggest a close interrelationship between peptidergic and CA nerve terminals in the neurogenic control of cerebral blood vessel function.
(1)大脑动脉壁中含血管活性肠肽(VIP)、P物质(SP)和神经肽Y(NPY)神经纤维的超微结构;(2)在电子显微镜下,通过免疫组织化学结合假递质(5-羟基多巴胺)组织化学方法,研究这些肽能(VIP、SP和NPY)与儿茶酚胺能(CA)神经末梢之间的关系。在神经末梢的轴浆和小清亮囊泡周围弥漫性地发现了VIP、SP和NPY样免疫反应性(VIPI、SPI和NPYI)。在少数情况下,SPI存在于大囊泡内。大多数VIPI末梢与CA末梢一起被施万细胞的胞质包绕,CA末梢被鉴定为含有许多小颗粒囊泡的末梢。在某些情况下,它们与平滑肌细胞直接相邻,距离约为100nm。SPI末梢常常是单个的,但约30%与CA末梢及其他(既非SPI也非CA)被施万细胞包绕的末梢一起定位,与平滑肌细胞直接相邻,距离约为100nm。另一方面,NPYI末梢也被鉴定为CA末梢,表明这两种物质共存。这些发现提示在脑血管功能的神经源性控制中,肽能和CA神经末梢之间存在密切的相互关系。